Fountain Report Excerpts Mar 27, 2024

Fountain Report Excerpts
  1. Chewy reported fourth quarter net sales of $2.83 billion, up 4.2%. Adjusted EBITDA of $86.5 million was down 11%. Net income was $31.9 million, up from $6.8 million last year. For the year, net sales of $11.1 billion was up 10%. Adjusted EBITDA of $368.1 million was up 20%. Net income of $39.6 million was down 21%. “In 2023, we gained market share while simultaneously expanding margins and accelerating free cash flow generation,” said CEO Sumit Singh.
  1. Leptospirosis continues to be prevalent in dogs, including in small-breed dogs from urban areas, puppies as young as 11 weeks of age, geriatric dogs, dogs in rural areas and dogs that have been inadequately vaccinated, according to the American College of Veterinary Internal Medicine’s revised consensus statement on leptospirosis. As such, ACVIM has updated its guidance and now recommends that all dogs be vaccinated for leptospirosis annually rather than every three years. The ACVIM statement touches on clinical and laboratory criteria to confirm leptospirosis in a dog; treatment options, including antimicrobial and extracorporeal kidney support therapies; supportive care; and prognosis. There is also guidance on vaccine protocols and public health implications, such as protecting veterinary staff from Leptospira infection, the AVMA reports.
  1. The finalization of a rule aligning the voluntary “Product of USA” label claim will prohibit misleading labeling and help ensure the information consumers receive about where their food comes from is truthful, the Ag Information Network reports. The USDA’s rule allows the voluntary “Product of USA” or “Made in the USA” label claim to be used on meat, poultry and egg products only when they’re derived from animals born, raised, slaughtered and processed in the United States.

Click HERE to subscribe to the full Fountain Report content.